MAK683

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAK683, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies [Phase 1]